Literature DB >> 8620487

Cloning and expression analysis of human bleomycin hydrolase, a cysteine proteinase involved in chemotherapy resistance.

A A Ferrando1, G Velasco, E Campo, C Lopez-Otin.   

Abstract

A cDNA encoding human bleomycin hydrolase, a member of the cysteine proteinase family of proteins, has been cloned from a human brain cDNA library. The isolated cDNA contains an open reading frame coding for a polypeptide of 456 amino acids that contains all of the structural features characteristic of cysteine proteinases, including the cysteine, histidine, and asparagine residues that are essential for the catalytic properties of these enzymes. The deduced amino acid sequence for human bleomycin hydrolase shows 92, 40, and about 35% of identities with those determined for rabbit bleomycin hydrolase, yeast bleomycin hydrolase, and bacterial aminopeptidase C, respectively. Northern blot analysis of poly(A)+ RNAs isolated from a variety of human tissues demonstrated that human bleomycin hydrolase is expressed in all examined tissues, which is consistent with a putative role of this protein as a proteolytic enzyme involved in norman cellular protein degradation and turnover. Preliminary expression analysis of bleomycin hydrolase in different human tumors showed increased expression of the enzyme in a series of head and neck carcinomas when compared with paired adjacent normal mucosa. We also observed a variable degree of bleomycin hydrolase expression in different types of lymphoma, with low or undetectable levels in Hodgkin's disease samples and higher levels in Burkitt's lymphomas. These results are consistent with a proposed role for human bleomycin hydrolase in resistance of some tumor to bleomycin chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8620487

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Comparative genome-scale analysis of gene expression profiles in T cell lymphoma cells during malignant progression using a complementary DNA microarray.

Authors:  S Li; D T Ross; M E Kadin; P O Brown; M A Wasik
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

2.  Mechanisms of resistance to alkylating agents.

Authors:  G Damia; M D'Incalci
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

3.  Experimental evidence for the essential role of the C-terminal residue in the strict aminopeptidase activity of the thiol aminopeptidase PepC, a bacterial bleomycin hydrolase.

Authors:  L Mata; M Erra-Pujada; J C Gripon; M Y Mistou
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

4.  Bleomycin hydrolase is regulated biphasically in a differentiation- and cytokine-dependent manner: relevance to atopic dermatitis.

Authors:  Yayoi Kamata; Mami Yamamoto; Fumitaka Kawakami; Ryoji Tsuboi; Atsushi Takeda; Kazuhiko Ishihara; Toshihiko Hibino
Journal:  J Biol Chem       Date:  2010-12-29       Impact factor: 5.157

5.  The neutral cysteine protease bleomycin hydrolase is essential for epidermal integrity and bleomycin resistance.

Authors:  D R Schwartz; G E Homanics; D G Hoyt; E Klein; J Abernethy; J S Lazo
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

6.  Astrogliosis and behavioral changes in mice lacking the neutral cysteine protease bleomycin hydrolase.

Authors:  S E Montoya; E Thiels; J P Card; J S Lazo
Journal:  Neuroscience       Date:  2007-03-27       Impact factor: 3.590

7.  A computational framework discovers new copy number variants with functional importance.

Authors:  Samprit Banerjee; Derek Oldridge; Maria Poptsova; Wasay M Hussain; Dimple Chakravarty; Francesca Demichelis
Journal:  PLoS One       Date:  2011-03-29       Impact factor: 3.240

8.  Effect of Bleomycin Hydrolase Gene Polymorphism on Late Pulmonary Complications of Treatment for Hodgkin Lymphoma.

Authors:  Ádám Jóna; Zsófia Miltényi; Szilárd Póliska; Bálint László Bálint; Árpád Illés
Journal:  PLoS One       Date:  2016-06-21       Impact factor: 3.240

9.  Intrinsic sensitivity of tumor cells to bleomycin as an indicator of tumor response to electrochemotherapy.

Authors:  M Cemazar; D Miklavcic; G Sersa
Journal:  Jpn J Cancer Res       Date:  1998-03

10.  Mesenchymal stem cells are sensitive to bleomycin treatment.

Authors:  Nils H Nicolay; Alexander Rühle; Ramon Lopez Perez; Thuy Trinh; Sonevisay Sisombath; Klaus-Josef Weber; Anthony D Ho; Jürgen Debus; Rainer Saffrich; Peter E Huber
Journal:  Sci Rep       Date:  2016-05-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.